Rebuttal From Dr Nathan von Nathan, Steven D.

Volltext

Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease von Nathan, Steven D

Volltext

The Future of Lung Transplantation von Nathan, Steven D., MD, FCCP

Volltext

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes von Nathan, Steven D., Deng, Chunqin, King, Christopher S., DuBrock, Hilary M., Elwing, Jean, Rajagopal, Sudarshan, Rischard, Franz, Sahay, Sandeep, Broderick, Meredith, Shen, Eric, Smith, Peter, Tapson, Victor F., Waxman, Aaron B.

Volltext

Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry von Shlobin, Oksana A, Kouranos, Vasilis, Barnett, Scott D, Alhamad, Esam H, Culver, Daniel A, Barney, Joseph, Cordova, Francis C, Carmona, Eva M, Scholand, Mary Beth, Wijsenbeek, Marlies, Ganesh, Sivagini, Lower, Elyse E, Engel, Peter J, Wort, John, Price, Laura, Wells, Athol U, Nathan, Steven D, Baughman, Robert P

Volltext

Reply to Jin et al .: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question von Nathan, Steven D

Volltext

IPF clinical trial design and endpoints von Nathan, Steven D, Meyer, Keith C

Volltext

Phenotypes of idiopathic pulmonary arterial hypertension von El-Kersh, Karim, Nathan, Steven D

Volltext

IPF in Saudi Arabia: Lessons for all von Nathan, Steven

Volltext

Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data von Kim, Su Yeon, PhD, Diggans, James, PhD, Pankratz, Dan, PhD, Huang, Jing, PhD, Pagan, Moraima, PhD, Sindy, Nicole, MBS, Tom, Ed, BA, Anderson, Jessica, MS, Choi, Yoonha, PhD, Lynch, David A, Prof, Steele, Mark P, Prof, Flaherty, Kevin R, MD, Brown, Kevin K, Prof, Farah, Humam, MD, Bukstein, Michael J, MD, Pardo, Annie, Prof, Selman, Moisés, MD, Wolters, Paul J, MD, Nathan, Steven D, Prof, Colby, Thomas V, Prof, Myers, Jeffrey L, Prof, Katzenstein, Anna-Luise A, Prof, Raghu, Ganesh, Prof, Kennedy, Giulia C, Dr

Volltext

POINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? Yes von Nathan, Steven D.

Volltext

Response to: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD von Nathan, Steven D., Kim, Ho Cheol, Chandel, Abhimanyu

Volltext

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry von Baughman, Robert P., Shlobin, Oksana A., Wells, Athol U., Alhamad, Esam H., Culver, Daniel A., Barney, Joseph, Cordova, Francis C., Carmona, Eva M., Scholand, Mary Beth, Wijsenbeek, Marlies, Ganesh, Sivagini, Birring, Surinder S., Kouranos, Vasilis, O'Hare, Lanier, Baran, Joanne M., Cal, Joseph G., Lower, Elyse E., Engel, Peter J., Nathan, Steven D.

Volltext

Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the Future von Nathan, Steven D

Volltext

Inhaled Treprostinil in Group 3 Pulmonary Hypertension. Reply von Nathan, Steven D, Waxman, Aaron, Tapson, Victor

Volltext

Piecing together the bigger picture: Idiopathic pulmonary fibrosis in Australia and beyond von Chandel, Abhimanyu, Nathan, Steven D.

Volltext

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis von Nathan, Steven D, Shlobin, Oksana A, Barnett, Scott D, Saggar, Rajeev, Belperio, John A, Ross, David J, Ahmad, Shahzad, Saggar, Rajan, Libre, Eric, Lynch, Joseph P, Zisman, David A

Volltext

The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis von Brown, A Whitney, Nathan, Steven D

Volltext

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation von SHLOBIN, Oksana A, NATHAN, Steven D

Volltext

Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia von King, Christopher S, Brown, A Whitney, Shlobin, Oksana A, Weir, Nargues, Libre, Matthew, Franco-Palacios, Domingo, Ahmad, Shahzad, Nathan, Steven D

Volltext